C反应蛋白检测在呼吸系统疾病诊治中的应用

王春艳, 何权瀛

王春艳, 何权瀛. C反应蛋白检测在呼吸系统疾病诊治中的应用[J]. 实用临床医药杂志, 2004, (2): 31-33. DOI: 10.3969/j.issn.1672-2353.2004.02.012
引用本文: 王春艳, 何权瀛. C反应蛋白检测在呼吸系统疾病诊治中的应用[J]. 实用临床医药杂志, 2004, (2): 31-33. DOI: 10.3969/j.issn.1672-2353.2004.02.012
Use of CRP examination in the treatment of respiratory diseases[J]. Journal of Clinical Medicine in Practice, 2004, (2): 31-33. DOI: 10.3969/j.issn.1672-2353.2004.02.012
Citation: Use of CRP examination in the treatment of respiratory diseases[J]. Journal of Clinical Medicine in Practice, 2004, (2): 31-33. DOI: 10.3969/j.issn.1672-2353.2004.02.012

C反应蛋白检测在呼吸系统疾病诊治中的应用

详细信息
  • 中图分类号: R56

Use of CRP examination in the treatment of respiratory diseases

  • 摘要: C反应蛋白(CRP)是人体血浆中的一种正常蛋白组分,含量甚微.早在1930年由Tillett和Francis首次在大叶性肺炎患者血清中发现,为一种在Ca2+存在时能与肺炎球菌细胞壁中的C-多糖发生特异性沉淀反应的物质,后被证实为一种急性时相蛋白(Acute phase protein), 被誉为炎症标志物[1].在组织感染性炎症和急性损伤时, CRP可明显升高,当感染控制和组织修复后CRP可迅速恢复,与病情变化同步[2].随着许多灵敏、准确、快速而简便的检测手段相继问世,近年来对CRP的研究进展较快,现就CRP测定在呼吸疾病诊治中的应用进行综述.
  • Roberts W L, Sedrick R, Moelton L. Evaluation of four automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications [J]. Clinical Chemistry, 2000(4):461.
    濮跃晨. 全自动血培养系统检测730份分析 [J]. 中华检验医学杂志, 2000(2):102.doi: 10.3760/j:issn:1009-9158.2000.02.029.
    Kilpatrick J M, Volannakis J E. Molecular genetics, structure, and function of C-reactive protein [J]. IMMUNOLOGIC RESEARCH, 1991(1):43.doi: 10.1007/BF02918166.
    Jialal I, Stein D, Balis D. Effects of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high senstitve C-reactive protein levels [J]. Circulation, 2001.1933.
    Steel D M, Whitehead A S. The major acute phase reactants:C-reative protain, serum amyloid P component and serum amyloid A protein [J]. Immunology Today, 1994.81.doi: 10.1016/0167-5699(94)90138-4.
    Buck C, Bundschu J, Gallati H. Interleukin-6:a sensitive parameter for the early diagnosis of neonatal bacterial infection [J]. PEDIATRICS, 1994.54.
    Mold C, Gewurz H, Du Clos T W. Regulation of complement activation by C-reactive protein [J]. IMMUNOPHARMACOLOGY, 1999, (1-3):23.doi: 10.1016/S0162-3109(99)00007-7.
    Mortensen R F, Zhong W. Regulation of phagocytic leukocyte activities by C-reactive protein [J]. Journal of Leukocyte Biology, 2000(4):495.
    Fiedel B A, Simpson R M, Gewurz H. Effects of C-reactive protein(CRP) on platelet function [J]. Annals of the New York Academy of Sciences, 1982.263.
    杨振修. C反应蛋白的检测 [J]. 上海医学检验杂志, 1999(5):261.
    Jaye D L, Waites K B. Clinical applications of C-reative protein in pediatrics [J]. Pediatric Infectious Disease Journal, 1997.735.doi: 10.1097/00006454-199708000-00003.
    Gambino R. C-reactive protein-undervalued, underutilized [J]. Clinical Chemistry, 1997, (11):2017.
    Korppi M, Heiskanen Kosma J, Leinonen M. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children [J]. European Respiratory Journal, 1997(5):1125.
    Hopstaken R M, Muris J W, Knottnerus J A. Contributions of symptoms, sing, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection [J]. British Journal of General Practice, 2003, (490):358.
    Dev D, Wallace E, Sankaran R. Value of C-reative protein measurements in exacerbations of chronic obstructive pulmonary disease [J]. Respiratory Medicine, 1998(4):664.doi: 10.1016/S0954-6111(98)90515-7.
    Toikka P, Irjala K, Juven T. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children [J]. Pediatric Infectious Disease Journal, 2000(7):598.
    Garcia Vazquez E, Martinez J A. C-reactive protein levels in community-acquired pneumonia [J]. European Respiratory Journal, 2003(4):702.doi: 10.1183/09031936.03.00080203.
    杨恂, 官和立, 姚薇. 检测慢性支气管炎患者血清、痰中白细胞介素及C反应蛋白的临床意义 [J]. 临床内科杂志, 2003, (10):539.doi: 10.3969/j.issn.1001-9057.2003.10.016.
    Crooks S W, Bayley D L, Hill S L. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis:the rate of leukotriene B4 [J]. European Respiratory Journal, 2000(2):274.doi: 10.1034/j.1399-3003.2000.15b09.x.
    Lawn S D, Obeng J, Acheampong J W. Resolution of the acute-phase response in West African patients receiving treatment for pulmonary tuberculosis [J]. International Journal of Tuberculosis and Lung Disease, 2000(4):340.
    Lee J H, Chang J H. Changs of plasma interleukin-1 receptor antagonist, interleukin-8 and other serologic markers during chemotherapy in patients with active pulmonary tuberculosis [J]. Korean Journal of Internal Medicine, 2003(3):138.
    Yilmaz Turay U, Yildirim E, Turkoz Y. Use of pleural fluid C-reative protein in diagnosis of pleural effusions [J]. Respiratory Medicine, 2000(5):432.doi: 10.1053/rmed.1999.0759.
    黄建达, 蔡挺. C反应蛋白、触珠蛋白在胸腔积液鉴别诊断中的价值 [J]. 临床内科杂志, 2001(3):192.doi: 10.3969/j.issn.1001-9057.2001.03.013.
    Scote H R, Mcmillan D C, Brown D J. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small-cell lung cancer [J]. Lung Cancer, 2003(3):295.
    Kato K, Hitsudn Y, Kawasaki Y. The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer [J]. Nihon KoKyuKi GaKKai Zasshi, 2000(8):578.
    Aujesky D, Hayoz D, Yersin B. Exclusion of pulmonary embolism using C-reactive protein and D-dimer.A prospective comparison [J]. Thrombosis and Haemostasis, 2003(6):1198.
    Horney E, Lagerstedt C. Evaluation of analyses to exclude suspected thrombosis.don, t rely on the D-dimer test [J]. Lakartidningen, 1998, (1-2):55.
计量
  • 文章访问数:  118
  • HTML全文浏览量:  21
  • PDF下载量:  12
  • 被引次数: 0
出版历程
  • 发布日期:  2004-07-30

目录

    /

    返回文章
    返回